WHO Declares Ebola Emergency

As the World Health Organization calls the ongoing Ebola outbreak in West Africa an international public health emergency, the US Food and Drug Administration green-lights the potential use of another experimental drug.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDC PUBLIC HEALTH IMAGE LIBRARYThe World Health Organization (WHO) today (August 8) declared the ongoing Ebola outbreak in West Africa a Public Health Emergency of International Concern (PHEIC), the third-ever PHEIC designation the agency has issued. To date, 1,711 people have been reported as infected with the deadly virus, and 932 people in West Africa have died. “This is currently the largest EVD [Ebola virus disease] outbreak ever recorded,” the WHO reiterated in its statement.

The declaration, epidemiologist Jeffrey Duchin from the University of Washington told Nature News, “tells us is that this is a really serious problem right now in West Africa that requires a full-court press by the international community to get it under control.”

Meanwhile, the US Food and Drug Administration (FDA) has modified the hold it placed on Tekmira Pharmaceutical’s Investigational New Drug application for TKM-Ebola, enabling “the potential use of TKM-Ebola in individuals infected with Ebola virus,” the firm announced yesterday (August 7).

“We are pleased that the FDA has considered the risk-reward of TKM-Ebola for infected patients,” Mark Murray, Tekmira’s CEO and president, said in the statement. “We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems